1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Autoimmune Experimental Myasthenia Gravis in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| Zhang, M | 1 |
| Wang, CC | 1 |
| Li, XL | 1 |
| Zhang, P | 1 |
| Yue, LT | 1 |
| Miao, S | 1 |
| Dou, YC | 1 |
| Li, YB | 1 |
| Duan, RS | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Autoimmune Experimental Myasthenia Gravis
| Article | Year |
|---|---|
ROCK inhibitor abolishes the antibody response in experimental autoimmune myasthenia gravis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Autoimmunity; B-Lymphocytes; Female; Germina | 2016 |